Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

Condition:   HealthyInterventions:   Drug: Niaspan;   Drug: TRIA-662Sponsors:   Cortria Corporation;   Cortria Corporation;   PPD;   Pharmena North AmericaCompleted - verified August 2013

Source: ClinicalTrials.gov - March 8, 2013 Category: Research Source Type: clinical trials